Target intelligence / Profile preview

Human Immunodeficiency Virus Envelope Glycoprotein (Env)

Target
Env
Molecular classification
Viral protein, Glycoprotein, Fusion protein, Membrane protein
01

Overview

The human immunodeficiency virus (HIV) envelope glycoprotein, commonly referred to as Env, is a complex protein structure found on the surface of HIV-1 and HIV-2 virions. It plays a central role in viral entry into host cells and is the primary target for neutralizing antibodies and vaccine design efforts. The Env glycoprotein is synthesized as a precursor protein called gp160, which undergoes proteolytic cleavage to yield two non-covalently associated subunits: gp120 (the external subunit responsible for binding to host cell receptors) and gp41 (the transmembrane subunit that mediates fusion between the viral envelope and the host cell membrane). On mature virions, three gp120-gp41 heterodimers assemble into a trimeric spike complex embedded in the viral membrane. Env is essential for determining HIV tropism, mediating initial attachment and subsequent entry steps, and serving as an immunodominant antigen.

Other names
HIV Envelope Glycoproteingp160gp120gp41
02

Mechanism of action

Block receptor/coreceptor interactions or prevent necessary conformational changes required for fusion

03

Biological functions

Viral entryReceptor bindingMembrane fusionImmune evasionTropism determination
04

Disease associations

HIV infectionAIDS
05

Safety considerations

High sequence variabilityExtensive glycan shieldingEliciting broadly neutralizing antibodies
06

Interacting drugs

Entry inhibitors (e.g., small molecules, peptides)

1 more in the full profile.

Beyond the preview

Go deeper on Human Immunodeficiency Virus Envelope Glycoprotein (Env).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human Immunodeficiency Virus Envelope Glycoprotein (Env).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call